A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy
Clinical trial NCT03525574 · COMPLETED
Trial details
- NCT number
- NCT03525574
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-09
- Primary completion
- 2023-01-09
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.